1. Comparative pharmacokinetics and bioavailability of brimonidine following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate‐to‐severe facial erythema associated with rosacea. (16th July 2014) Authors: Benkali, K.; Leoni, M.; Rony, F.; Bouer, R.; Fernando, A.; Graeber, M.; Wagner, N. Journal: British journal of dermatology Issue: Volume 171:Number 1(2014:Jul.) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative pharmacokinetics and bioavailability of brimonidine following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate‐to‐severe facial erythema associated with rosacea. (1st July 2014) Authors: Benkali, K.; Leoni, M.; Rony, F.; Bouer, R.; Fernando, A.; Graeber, M.; Wagner, N. Journal: British journal of dermatology Issue: Volume 171:Number 1(2014:Jul.) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of mogamulizumab in previously treated patients with less advanced mycosis fungoides (MF): results from the MAVORIC study. (2019) Authors: Scarisbrick, J.; Geskin, L.J.; Bagot, M.; Fisher, D.C.; Elmets, C.; Duvic, M.; Beylot-Barry, M.; Kim, E.J.; Moriya, J.; Leoni, M.; Zinzani, P.L. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EFFICACY OF MOGAMULIZUMAB IN PREVIOUSLY TREATED PATIENTS WITH LESS ADVANCED MYCOSIS FUNGOIDES: RESULTS FROM THE MAVORIC STUDY. (12th June 2019) Authors: Scarisbrick, J.; Geskin, L.J.; Bagot, M.; Fisher, D.C.; Elmets, C.; Duvic, M.; Beylot‐Barry, M.; Kim, E.J.; Moriya, J.; Leoni, M.; Zinzani, P.L. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Fatigue and biological properties of Ti-6Al-4V ELI cellular structures with variously arranged cubic cells made by selective laser melting. (February 2018) Authors: Dallago, M.; Fontanari, V.; Torresani, E.; Leoni, M.; Pederzolli, C.; Potrich, C.; Benedetti, M. Journal: Journal of the mechanical behavior of biomedical materials Issue: Volume 78(2018) Page Start: 381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. HNSCCs overexpressing wild-type HRAS are sensitive to combined tipifarnib and alpelisib treatment. (October 2022) Authors: Soifer, H.; Mishra, V.; Malik, S.; Smith, A.; Chan, S.; Kessler, L.; Burrows, F.; Leoni, M.; Saunders, A.; Dale, S. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Report on the To.Sca.Lat.-1.0 Summer School, total scattering analysis for nanoscience in Latin America. Issue 2 (June 2019) Authors: Campos, C. E. M.; Ulbrich, K. F.; Leoni, M.; Masciocchi, N.; Bertolotti, F.; Guagliardi, A. Journal: Powder diffraction Issue: Volume 34:Issue 2(2019) Page Start: 203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The effect of post-sintering treatments on the fatigue and biological behavior of Ti-6Al-4V ELI parts made by selective laser melting. (July 2017) Authors: Benedetti, M.; Torresani, E.; Leoni, M.; Fontanari, V.; Bandini, M.; Pederzolli, C.; Potrich, C. Journal: Journal of the mechanical behavior of biomedical materials Issue: Volume 71(2017) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. TIME TO NEXT TREATMENT IN PATIENTS WITH PREVIOUSLY TREATED CUTANEOUS T‐CELL LYMPHOMA (CTCL) RECEIVING MOGAMULIZUMAB OR VORINOSTAT: A POST‐HOC ANALYSIS OF THE MAVORIC STUDY. (12th June 2019) Authors: Kim, Y.H.; Ortiz‐Romero, P.L.; Pro, B.; Sokol, L.; Scarisbrick, J.; Musiek, A.; Vermeer, M.; Dummer, R.; Halwani, A.; Fierro, M.; Moriya, J.; Leoni, M.; Bagot, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Treatment of facial erythema in patients with rosacea with topical brimonidine tartrate: correlation of patient satisfaction with standard clinical endpoints of improvement of facial erythema. (30th July 2014) Authors: Fowler, J.; Tan, J.; Jackson, J.M.; Meadows, K.; Jones, T.; Jarratt, M.; Leoni, M.; the Brimonidine Phase III Study Group Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 3(2015:Mar.) Page Start: 474 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗